Don’t You Know that You’re Toxic? Cardiotoxicity Prevention and Treatment in Oncology

<p>Uzoamaka (Uzo) C. Abajue, PharmD (<a href='https://twitter.com/Uzo_Chi'>@Uzo_Chi</a>) discusses the manifestations, diagnosis, and classification of chemotherapy induced cardiotoxicity, identifies causative oncologic agents responsible for cardiotoxicities and outlines strategies for cardiotoxicity management due to oncologic agents.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>